![Nicole Vitullo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicole Vitullo
Director/Board Member at
Bioscience Managers Pty Ltd.
Net worth: 115 553 $ as of 31/05/2026
Profile
Nicole Vitullo is currently Director at Rosetta Capital Ltd. since 2017, Independent Director at Bioscience Managers Pty Ltd., Director at Hinge Bio, Inc., Director at Allay Therapeutics, Inc. since 2023, Director at Iterum Therapeutics, Inc., Partner at Domain Associates LLC since 1999, Managing Member at One Palmer Square Associates VIII LLC, Venture Advisor at Agent Capital LLC, Board Member at Antios Therapeutics, Inc. since 2018, and Venture Partner at Arboretum Ventures LLC since 2023.
Former roles include Chairman at Immedica Pharma US, Inc., Director-Communications & Investor Relations at Cephalon LLC from 1991 to 1992, Director at Forest Laboratories, Inc., Director at Onyx Pharmaceuticals, Inc. from 1998 to 2005, Director at Psyadon Pharmaceuticals, Inc., Director at Cerexa, Inc., Director at Celtaxsys, Inc. from 2015 to 2023, Independent Director at Jazz Pharmaceuticals Therapeutics, Inc. from 2013 to 2016, Director at VentiRx Pharmaceuticals, Inc., Director at Calixa Therapeutics, Inc., Director at Cotera, Inc., Independent Director at Esperion Therapeutics, Inc. from 2022 to 2025, Director at Eunoe, Inc., Independent Director at Durata Therapeutics, Inc. from 2009 to 2014, Director at Antios Therapeutics, Inc., Director at Exalys Therapeutics, Inc., Director at Achillion Pharmaceuticals, Inc. from 2010 to 2019, Principal at Eastman Kodak Co., and Senior Vice President at Rothschild & Co. Asset Management US, Inc. from 1992 to 1999.
Education includes an undergraduate degree conferred in 1979 and an MBA conferred in 1990, both from the University of Rochester.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/05/2025 | 36,918 ( 0.01% ) | 115 553 $ | 31/05/2026 |
Nicole Vitullo active positions
| Companies | Position | Start |
|---|---|---|
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates invests in both private and public companies located in the United States. The firm focuses on pharmaceuticals, diagnostics and medical device sectors. It provides financing for seed, early and late stage capital requirements. It takes a seat on the board of directors. | Private Equity Investor | 01/01/1999 |
One Palmer Square Associates VIII LLC | Corporate Officer/Principal | - |
Rosetta Capital Ltd.
 Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital invests in early and mid-stage growth companies in biotechnology-related sectors. The firm invest in acquisition financing and spin-off transactions. | Private Equity Investor | 30/10/2017 |
Bioscience Managers Pty Ltd.
 Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Director/Board Member | - |
Agent Capital LLC
 Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Consultant / Advisor | - |
Allay Therapeutics, Inc.
 Allay Therapeutics, Inc. Information Technology ServicesTechnology Services Develops technology for healthcare industry | Director/Board Member | 06/09/2023 |
Hinge Bio, Inc.
 Hinge Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for autoimmune and inflammatory & cancer diseases | Director/Board Member | - |
Antios Therapeutics, Inc.
 Antios Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company focused on development of innovative therapies to treat and cure viral diseases | Director/Board Member | 01/12/2018 |
Iterum Therapeutics, Inc.
 Iterum Therapeutics, Inc. Iterum Therapeutics plc is a clinical-stage pharmaceutical company focused on developing anti-infectives to combat the crisis of multi-drug resistant pathogens. The company aims to improve the lives of people affected by serious and life-threatening diseases worldwide. Iterum is pursuing a balanced development strategy to treat organisms responsible for serious infections that have not been adequately addressed by current therapies. The CDC and Infectious Disease Society of America have identified an urgent need for new therapies to combat increasing resistance, and Iterum's sulopenem is the first oral and penem antibiotic demonstrating a potent spectrum of activity against multi-drug resistant gram-negative infections. The company is located in the US. | Director/Board Member | - |
| ░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Former positions of Nicole Vitullo
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
58
1st degree connections
28
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 28 |
|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Eastman Kodak Co.
 Eastman Kodak Co. Industrial MachineryProducer Manufacturing Manufactures and markets digital printing products, industrial films & chemicals | Producer Manufacturing |
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Rothschild & Co. Asset Management US, Inc.
 Rothschild & Co. Asset Management US, Inc. Investment ManagersFinance R&Co actively manages their portfolios with a goal of outperforming the indices, whatever the market conditions, and with a controlled level of risk. The firm’s investment strategy is based on three key principles that drive their investment decisions regarding allocation, sector and stock selection. Their three core investment principles are Conviction, Fundamentals and Convexity. | Finance |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
Psyadon Pharmaceuticals, Inc.
 Psyadon Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Specializes in the development of drugs for central nervous system diseases | Retail Trade |
Marinus Pharmaceuticals, Inc.
 Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders | Health Technology |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Celtaxsys, Inc.
 Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Develops foundational therapies to treat inflammation in rare and orphan designated diseases | Health Technology |
Celator Pharmaceuticals, Inc.
 Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat acute myeloid leukemia and AML with myelodysplasia in children & adults | Health Technology |
VentiRx Pharmaceuticals, Inc.
 VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines | Health Technology |
Calixa Therapeutics, Inc.
 Calixa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes hospital-based anti-infective therapies | Health Technology |
Cotera, Inc.
 Cotera, Inc. Medical SpecialtiesHealth Technology Develops implantable devices for treatment of knee osteoarthritis | Health Technology |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates invests in both private and public companies located in the United States. The firm focuses on pharmaceuticals, diagnostics and medical device sectors. It provides financing for seed, early and late stage capital requirements. It takes a seat on the board of directors. | Finance |
Eunoe, Inc.
 Eunoe, Inc. Medical/Nursing ServicesHealth Services Provides treatment for neuro problems | Health Services |
Rosetta Capital Ltd.
Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital invests in early and mid-stage growth companies in biotechnology-related sectors. The firm invest in acquisition financing and spin-off transactions. | Finance |
One Palmer Square Associates VIII LLC | |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics for infectious diseases and acute illnesses | Health Technology |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Finance |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Finance |
Antios Therapeutics, Inc.
Antios Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company focused on development of innovative therapies to treat and cure viral diseases | Commercial Services |
Hinge Bio, Inc.
Hinge Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for autoimmune and inflammatory & cancer diseases | Health Technology |
Exalys Therapeutics, Inc.
 Exalys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Allay Therapeutics, Inc.
Allay Therapeutics, Inc. Information Technology ServicesTechnology Services Develops technology for healthcare industry | Technology Services |
Iterum Therapeutics, Inc.
Iterum Therapeutics, Inc. Iterum Therapeutics plc is a clinical-stage pharmaceutical company focused on developing anti-infectives to combat the crisis of multi-drug resistant pathogens. The company aims to improve the lives of people affected by serious and life-threatening diseases worldwide. Iterum is pursuing a balanced development strategy to treat organisms responsible for serious infections that have not been adequately addressed by current therapies. The CDC and Infectious Disease Society of America have identified an urgent need for new therapies to combat increasing resistance, and Iterum's sulopenem is the first oral and penem antibiotic demonstrating a potent spectrum of activity against multi-drug resistant gram-negative infections. The company is located in the US. | |
Arboretum Ventures LLC
 Arboretum Ventures LLC Investment ManagersFinance Arboretum Ventures invests in companies located in the United States. The firm focuses on medical devices, diagnostics, healthcare IT and healthcare services sectors. It participates in seed and early-stage capital requirements with an investment size of USD 10 - 15 million. | Finance |
- Stock Market
- Insiders
- Nicole Vitullo
